Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

NCT07371338 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease
Parkinson's Disease

Interventions

DRUG: IPS101A

Sponsor

Innopeutics Corporation